RIO DE JANEIRO, BRAZIL - On Saturday, September 12th, Oxford University announced the resumption of clinical trials of its experimental vaccine against Covid-19 after a brief interruption due to the detection of a suspected spinal cord inflammation in a woman vaccinated with the formula in the United Kingdom.
[UPDATE: Late Saturday, September 12th, Brazil's Federal Health Regulatory Agency ANVISA, after examining the data received from the UK, announced that it had authorized AstraZeneca . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here